09:52 AM EST - YM BioSciences Inc. : reported operational and financial results for its first quarter of fiscal 2012, ended September 30, 2011. Revenue from out-licensing for the first quarter of fiscal 2012 was $0.3 million compared with $0.3 million for the first quarter of fiscal 2011. For the first quarter of fiscal 2012, the Company incurred a gain of $5.4 million on the revaluation of warrants compared to a loss of $3.4 million for the first quarter of fiscal 2011. YM BioSciences Inc.
shares T.YM are trading even at $1.79.
